ASCEND WELLNESS HOLDINGS, INC.

AAWH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $-118.2M $-85.0M $-48.2M $-80.9M $-122.7M $-25.4M $-31.9M
Depreciation & Amortization $73.5M $66.2M $59.0M $37.1M $22.2M $12.6M $4.1M
Depreciation $41.6M $36.8M $34.2M $25.4M $14.8M $5.0M $1.5M
Amortization $30.2M $27.1M $23.6M $9.8M $6.8M $7.5M $2.1M
Stock-Based Compensation $2.4M $18.6M $19.8M $19.0M $23.1M $680.0K $311.0K
Net Cash from Operating Activities $38.1M $73.3M $75.3M $-38.4M $-41.7M $-6.0M $-40.9M
Investing Activities
Capital Expenditures $26.0M $22.5M $24.2M $81.6M $88.4M $26.4M $41.7M
Business Acquisitions $11.9M $9.8M $19.9M $25.1M $23.1M $26.0M $8.7M
Net Cash from Investing Activities $-45.7M $-37.2M $-59.9M $-114.3M $-113.2M $-30.9M $-65.6M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $5.1M $-20.4M $-17.1M $71.3M $252.4M $82.2M $111.1M
Net Change in Cash $-2.6M $15.7M $-1.6M $-81.3M $97.4M $45.3M $4.6M
Free Cash Flow $12.0M $50.8M $51.1M $-120.0M $-130.2M $-32.4M $-82.6M